Inhibition of Delta-Like Ligand 4 Induces Luteal Hypervascularization Followed by Functional and Structural Luteolysis in the Primate Ovary

by Fraser, Hamish M., Hastings, Julie M., Allan, Deborah, Morris, Keith D., Rudge, John S., Wiegand, Stanley J.
Published 2012

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

by Papadopoulos, Nicholas, Martin, Joel, Ruan, Qin, Rafique, Ashique, Rosconi, Michael P., Shi, Ergang, Pyles, Erica A., Yancopoulos, George D., Stahl, Neil, Wiegand, Stanley J.
Published 2012

A liver HIF-2α/IRS2 pathway sensitizes hepatic insulin signaling and is modulated by VEGF inhibition

by Wei, Kevin, Piecewicz, Stephanie M., McGinnis, Lisa M., Taniguchi, Cullen M., Wiegand, Stanley J., Anderson, Keith, Chan, Carol W-M., Mulligan, Kimberly X., Kuo, David, Yuan, Jenny, Vallon, Mario, Morton, Lori, Lefai, Etienne, Simon, M. Celeste, Maher, Jacquelyn J., Mithieux, Gilles, Rajas, Fabienne, Annes, Justin, McGuinness, Owen P., Thurston, Gavin, Giaccia, Amato J., Kuo, Calvin J.
Published 2013

Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

by MacDonald, Douglas A., Martin, Joel, Muthusamy, Kathir K., Luo, Jiann-Kae, Pyles, Erica, Rafique, Ashique, Huang, Tammy, Potocky, Terra, Liu, Yang, Cao, Jingtai, Bono, Françoise, Delesque, Nathalie, Savi, Pierre, Francis, John, Amirkhosravi, Ali, Meyer, Todd, Romano, Carmelo, Glinka, Meredith, Yancopoulos, George D., Stahl, Neil, Wiegand, Stanley J., Papadopoulos, Nicholas
Published 2016